Damoder Reddy Motati

Damoder Reddy Motati has a strong background in scientific research and development, with experience in various roles and companies. Damoder Reddy started their work experience in 2007 as a Research Scientist Trainee at AMRI, where they conducted research and development in bulk drug technologies. Damoder Reddy was proficient in utilizing various analytical instruments and techniques for R&D analysis.

In 2014, Damoder joined Union University as a Postdoctoral Research Associate, focusing on synthetic organic and medicinal chemistry. Damoder Reddy specialized in C-H functionalization, photocatalysis, and cascade reactions, with a particular application in the total synthesis of natural products and key intermediates. Damoder Reddy also played a role in designing and synthesizing small molecules to selectively inhibit the NOX4 enzyme for the treatment of cardiovascular disease and pulmonary fibrosis.

Damoder continued their research career at Emory University School of Medicine in 2019 as a Scientist. Their work involved the design, synthesis, and SAR analysis of small molecule antagonists for EP2 receptor targeting neuroinflammation to treat CNS disorders. Damoder Reddy also played a role in developing synthetic routes and procedures for PET-ligand synthesis for imaging and studying the EP2 receptor.

In 2021, they joined ActivX Biosciences as a Research Scientist, where they held roles as both a Senior Research Scientist and a Research Scientist. Their responsibilities included conducting research and analysis, with a focus on seniority in the later role.

Damoder's most recent work experience is as a Principal Scientist at Nine Square Therapeutics, starting in 2022. Additional details about this role are not provided.

Damoder Reddy Motati obtained a Doctor of Philosophy (PhD) degree in Organic Chemistry from the Indian Institute of Chemical Technology between the years 2009 and 2014.